Skip to main content

Any vaccine prepared for Corona in the world

 

The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.

The COVID-19 vaccine tracker:

  • Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-clinical development;
  • Provides analysis and visualization for several COVID-19 vaccine candidate categories;
  • Tracks the progress of each vaccine from pre-clinical, Phase 1, Phase 2 through to Phase 3 efficacy studies and including Phase 4 registered as interventional studies;
  • Provides links to published reports on safety, immunogenicity and efficacy data of the vaccine candidates;
  • Includes information on key attributes of each vaccine candidate and
  • Allows users to search for COVID-19 vaccines through various criteria such as vaccine platform, schedule of vaccination, route of administration, developer, trial phase and clinical endpoints.

The database is updated regularly - twice a week (Tuesday and Friday, 17:00 CET).

 

Submission of data

All data from independent institutions and vaccine developers are welcome to provide information on vaccine candidates being developed using the information template. Submitted data will be made openly accessible on a regular basis to enable fast data sharing.

Data extraction tools and sources

To ensure the latest information is available, the landscape will be updated twice a week (Tuesday and Friday, 17:00 CET) by searching, gathering and cross-checking data from multiple sources such as the Cochrane vaccine mapping tool, PubMed, ClinicalTrials.gov, WHO ICTRP and from a network of researchers and industry for new candidate vaccines by screening registered trials for clinical information.  Where data is missing, we either do not add any information (blank cells) or we supplement information gathered from press or public releases.  We welcome your feedback to help us update or make necessary changes, please note any updates will only be done twice a week.

Disclaimer

These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020 pandemic of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all) representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss, damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of these landscape documents. 

Contact us

The R&D Blueprint team is responsible for developing the COVID-19 candidate vaccine landscape database. For questions relating to the collection or sharing of data for novel COVID-19 vaccine candidates, please contact us at: rdblueprint@who.int

Useful information

Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process – A guidance document listing current COVID-19 vaccine candidates undergoing assessment for WHO Emergency Use Listing (EUL) and prequalification (PQ).

 

WHO TEAM
R&D Blue Print
EDITORS
World Health Organization

Comments

Post a Comment

Popular posts from this blog

How long will the Corona last

  How the Pandemic Will End The U.S. may end up with the worst COVID-19 outbreak in the industrialized world. This is how it’s going to play out. Joan Wong Story by  Ed Yong MARCH 25, 2020 HEALTH Like  ​The Atlantic ? Subscribe to  ​ The Atlantic Daily​ , our free weekday email newsletter. Editor’s Note:   The Atlantic  is making vital coverage of the coronavirus available to all readers. Find the collection  here . T hree months ago , no one knew that SARS-CoV-2 existed. Now the virus has spread to almost every country, infecting at least 446,000 people whom we know about, and many more whom we do not. It has crashed economies and broken health-care systems, filled hospitals and emptied public spaces. It has separated people from their workplaces and their friends. It has disrupted modern society on a scale that most living people have never witnessed. Soon, most everyone in the United States will know someone who has been infected. Like World War II ...
Post a Comment
Read more

How to motivate to get success

  there’s one thing I’ve learned from   being self-employed as a writer , it’s that motivation is a complex and fickle beast. Some days, I’m in a groove—I can crank out articles left and right, only taking a quick break to refill my coffee or eat lunch. Other days, I have to force myself not to surf Reddit and run unimportant errands. When motivation has to be intrinsic (meaning there’s no boss breathing down your neck to get things done), it can be harder to come by. Below, you’ll find a series of research-backed tips and tricks that entrepreneurs swear by when they’re stuck:1-To make strategy for success This is my go-to strategy. Over the past few years, I’ve identified the times when I’m most productive: 7:30 a.m. to 2 p.m., Monday through Thursday. I make sure to schedule the work that requires the most focus during these windows. I’ll never leave an article that’s due on a Monday morning, for example, for Friday afternoon because I know it’s unlikely I’ll muster the ment...
Post a Comment
Read more

Destructores contaminantes del mundo

 los contaminantes más peligrosos del mundo  / 26 de julio de 2017  Veintiocho productos químicos que causan problemas de salud, incluidos el cáncer y los trastornos reproductivos, y en ocasiones la muerte, están prohibidos o restringidos por el Convenio de Estocolmo, uno de los acuerdos internacionales más críticos administrados por ONU Medio Ambiente.  Conocidos como contaminantes orgánicos persistentes, o COP, la industria y la agricultura han liberado estas toxinas durante décadas y se han extendido por todas partes, incluso hasta el Ártico.  Permanecen intactos durante años en el medio ambiente y se “bioacumulan” en organismos que se encuentran más arriba en la red alimentaria, incluidos los peces grandes y los depredadores.  Envenenan tanto a las personas como a la vida silvestre.  Sus efectos también incluyen alergias e hipersensibilidad, daño al sistema nervioso y alteración del sistema inmunológico.  Algunos COP se consideran disruptores ...
Post a Comment
Read more